Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction-Reference-Cited by-同舟云学术

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

Published:2015-03 Issue:3 Volume:39 Page:296-306
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ramos F.,Thépot S.,Pleyer L.,Maurillo L.,Itzykson R.,Bargay J.,Stauder R.,Venditti A.,Seegers V.,Martínez-Robles V.,Burgstaller S.,Récher C.,Debén G.,Gaidano G.,Gardin C.,Musto P.,Greil R.,Sánchez-Guijo F.,Fenaux P.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference18 articles.

1. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment;Burnett;Cancer,2007

2. Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia;Fenaux;J Clin Oncol,2010

3. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia;Kantarjian;J Clin Oncol,2012

4. Azacitidine in untreated acute myeloid leukemia: a report on 149 patients;Thépot;Am J Hematol,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ven the dose matters: Venetoclax dosing in the frontline treatment of AML;Blood Reviews;2024-08

2. Cytosine analogues as DNA methyltransferase substrates;Nucleic Acids Research;2024-07-05

3. Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice;Journal of Personalized Medicine;2023-11-28

4. How to adjust therapy for elderly AML patients in developing countries?;The Egyptian Journal of Haematology;2023-10

5. Treatment of acute myeloid leukaemia in older patients – scope of intensive therapy? – A retrospective analysis;Hematology;2023-05-19